These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6453435)

  • 1. Differential effect of high affinity heparin and low affinity heparin on methylene blue titration.
    Villanueva GB; Danishefsky I
    Thromb Res; 1981 Jan 1-15; 21(1-2):191-9. PubMed ID: 6453435
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
    Scully MF; Ellis V; Seno N; Kakkar VV
    Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of heparin with myosin ATPase: possible involvement with the hemorrhagic activity and a correlation with antithrombin III high affinity-heparin molecules.
    Tersariol IL; Dietrich CP; Nader HB
    Thromb Res; 1992 Nov; 68(3):247-58. PubMed ID: 1471071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of sulphation of glycosaminoglycans in their structural and functional characteristics.
    Németh-Csoka M; Kajtár M; Kajtár J
    Connect Tissue Res; 1977; 5(1):1-6. PubMed ID: 141357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding of chondroitin 6-sulfate to plasma low density lipoprotein.
    Mourão PA; Pillai S; Di Ferrante N
    Biochim Biophys Acta; 1981 May; 674(2):178-87. PubMed ID: 6786361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin and first complement protein recognize the same active heparin fraction.
    Calabrese GC; Recondo EF; Fernandez de Recondo ME
    Thromb Res; 2002 Mar; 105(6):537-41. PubMed ID: 12091056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.
    Hovingh P; Piepkorn M; Linker A
    Biochem J; 1986 Jul; 237(2):573-81. PubMed ID: 2948492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the early stages of the thrombin generation reaction by various glycosaminoglycans.
    Visser A; Meuleman DG
    Thromb Res; 1990 Jun; 58(5):469-79. PubMed ID: 2164263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of interleukin 7 (IL-7) with glycosaminoglycans and its biological relevance.
    Clarke D; Katoh O; Gibbs RV; Griffiths SD; Gordon MY
    Cytokine; 1995 May; 7(4):325-30. PubMed ID: 8589262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of heparin fractions and other polysulfated polysaccharides to plasma fibronectin: effects of molecular size and degree of sulfation of polysaccharides.
    Ogamo A; Nagai A; Nagasawa K
    Biochim Biophys Acta; 1985 Jul; 841(1):30-41. PubMed ID: 2861857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of low molecular weight heparin effect on the relation between anticoagulant activity and antithrombin III affinity.
    Hamano S; Nishiyama M; Kikuchi S; Komatsu H; Miyata H; Ikeda S; Sakuragawa N
    Thromb Res; 1992 May; 66(4):299-307. PubMed ID: 1329257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of chemical and biologic properties of a fraction of sulodexide, a heparin-like glycosaminoglycan.
    Radhakrishnamurthy B; Sharma C; Bhandaru RR; Berenson GS; Stanzani L; Mastacchi R
    Atherosclerosis; 1986 May; 60(2):141-9. PubMed ID: 3087374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
    Nagasawa K; Uchiyama H
    J Biochem; 1984 Mar; 95(3):619-26. PubMed ID: 6725227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant mechanisms of Orgaran (Org 10172) and its fraction with high affinity to antithrombin III (Org 10849).
    Ofosu FA
    Haemostasis; 1992; 22(2):66-72. PubMed ID: 1379966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anticoagulant properties of mast cell product, chondroitin sulphate E.
    Scully MF; Ellis V; Seno N; Kakkar VV
    Biochem Biophys Res Commun; 1986 May; 137(1):15-22. PubMed ID: 3087353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies of biologic properties of a polysulfated chondroitin, A73025.
    Radhakrishnamurthy B; Godofsky A; Dalferes ER; Srinivasan S; Vijayagopal P; Berenson G
    Proc Soc Exp Biol Med; 1980 Sep; 164(4):410-4. PubMed ID: 7413661
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of inhibition of mammalian DNA topoisomerase I by heparin.
    Ishii K; Futaki S; Uchiyama H; Nagasawa K; Andoh T
    Biochem J; 1987 Jan; 241(1):111-9. PubMed ID: 3032152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective binding of zinc ions to heparin rather than to other glycosaminoglycans.
    Parrish RF; Fair WR
    Biochem J; 1981 Feb; 193(2):407-10. PubMed ID: 6796046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticoagulant properties of heparin and heparin fractions.
    Holmer E
    Scand J Haematol Suppl; 1980; 36():25-39. PubMed ID: 6935760
    [No Abstract]   [Full Text] [Related]  

  • 20. Neutralization of the anticoagulant effects of glycosaminoglycans by serum amyloid P component: comparison with other plasma and platelet proteins.
    Williams EC; Huppert BJ; Asakura S
    J Lab Clin Med; 1992 Jul; 120(1):159-67. PubMed ID: 1377216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.